PDB Short entry for 1WYI HEADER ISOMERASE 14-FEB-05 1WYI TITLE HUMAN TRIOSEPHOSPHATE ISOMERASE OF NEW CRYSTAL FORM COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRIOSEPHOSPHATE ISOMERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: TIM, TRIOSE-PHOSPHATE ISOMERASE; COMPND 5 EC: 5.3.1.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: DH5A; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PTRCHIS B (INVITROGEN) KEYWDS TIM, MICROGRAVITY, NEW CRYSTAL FORM, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.KINOSHITA REVDAT 7 13-MAR-24 1WYI 1 SEQADV REVDAT 6 11-OCT-17 1WYI 1 REMARK REVDAT 5 13-JUL-11 1WYI 1 VERSN REVDAT 4 24-FEB-09 1WYI 1 VERSN REVDAT 3 21-JUN-05 1WYI 1 JRNL REVDAT 2 26-APR-05 1WYI 1 JRNL REVDAT 1 12-APR-05 1WYI 0 JRNL AUTH T.KINOSHITA,R.MARUKI,M.WARIZAYA,H.NAKAJIMA,S.NISHIMURA JRNL TITL STRUCTURE OF A HIGH-RESOLUTION CRYSTAL FORM OF HUMAN JRNL TITL 2 TRIOSEPHOSPHATE ISOMERASE: IMPROVEMENT OF CRYSTALS USING THE JRNL TITL 3 GEL-TUBE METHOD. JRNL REF ACTA CRYSTALLOGR.,SECT.F V. 61 346 2005 JRNL REFN ESSN 1744-3091 JRNL PMID 16511037 JRNL DOI 10.1107/S1744309105008341 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : 3.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 345676.900 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 64.6 REMARK 3 NUMBER OF REFLECTIONS : 15864 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.266 REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.296 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 773 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 23600 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 37.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1418 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE : 0.3630 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 79 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.041 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3736 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 460 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.20000 REMARK 3 B22 (A**2) : 6.17000 REMARK 3 B33 (A**2) : 2.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.24 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.820 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.460 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.390 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.890 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.640 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABINET REMARK 3 KSOL : NULL REMARK 3 BSOL : 280.0 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESOLUTION-DEPENDENT WEIGHTING SCHEME REMARK 4 REMARK 4 1WYI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-FEB-05. REMARK 100 THE DEPOSITION ID IS D_1000024154. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-DEC-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23600 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 28.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX 2002 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, MGCL2, PH 8.0, GEL-TUBE UNDER REMARK 280 MICROGAVITY, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.28200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.70600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.44150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.70600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.28200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.44150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 23.28200 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 35.44150 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 141.41200 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3320 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 2 73.48 -61.90 REMARK 500 SER A 3 37.36 -79.44 REMARK 500 LYS A 13 -147.04 54.50 REMARK 500 PRO A 57 -19.46 -45.49 REMARK 500 ASN A 65 173.06 177.91 REMARK 500 LYS A 130 -179.67 -68.18 REMARK 500 VAL A 196 -82.41 -107.01 REMARK 500 SER B 3 102.38 -58.18 REMARK 500 LYS B 13 -135.82 61.40 REMARK 500 MET B 14 75.53 -106.99 REMARK 500 ASN B 65 166.78 177.09 REMARK 500 GLU B 135 34.19 -78.43 REMARK 500 ALA B 136 -13.10 -140.36 REMARK 500 LYS B 159 52.67 -113.54 REMARK 500 TRP B 168 7.74 -65.64 REMARK 500 ALA B 169 80.45 -177.96 REMARK 500 THR B 177 122.93 -38.42 REMARK 500 VAL B 196 -80.60 -133.36 REMARK 500 SER B 197 144.22 -171.67 REMARK 500 SER B 203 -4.47 -145.25 REMARK 500 ILE B 206 77.23 -116.03 REMARK 500 ALA B 215 -57.32 -121.92 REMARK 500 ASP B 225 59.93 -102.70 REMARK 500 ASP B 227 35.33 -96.81 REMARK 500 VAL B 231 126.98 -38.62 REMARK 500 ASN B 245 63.77 -100.42 REMARK 500 ALA B 246 40.39 -80.36 REMARK 500 REMARK 500 REMARK: NULL DBREF 1WYI A 1 248 UNP P60174 TPIS_HUMAN 1 248 DBREF 1WYI B 1 248 UNP P60174 TPIS_HUMAN 1 248 SEQADV 1WYI GLY A -1 UNP P60174 CLONING ARTIFACT SEQADV 1WYI SER A 0 UNP P60174 CLONING ARTIFACT SEQADV 1WYI GLY B -1 UNP P60174 CLONING ARTIFACT SEQADV 1WYI SER B 0 UNP P60174 CLONING ARTIFACT SEQRES 1 A 250 GLY SER ALA PRO SER ARG LYS PHE PHE VAL GLY GLY ASN SEQRES 2 A 250 TRP LYS MET ASN GLY ARG LYS GLN SER LEU GLY GLU LEU SEQRES 3 A 250 ILE GLY THR LEU ASN ALA ALA LYS VAL PRO ALA ASP THR SEQRES 4 A 250 GLU VAL VAL CYS ALA PRO PRO THR ALA TYR ILE ASP PHE SEQRES 5 A 250 ALA ARG GLN LYS LEU ASP PRO LYS ILE ALA VAL ALA ALA SEQRES 6 A 250 GLN ASN CYS TYR LYS VAL THR ASN GLY ALA PHE THR GLY SEQRES 7 A 250 GLU ILE SER PRO GLY MET ILE LYS ASP CYS GLY ALA THR SEQRES 8 A 250 TRP VAL VAL LEU GLY HIS SER GLU ARG ARG HIS VAL PHE SEQRES 9 A 250 GLY GLU SER ASP GLU LEU ILE GLY GLN LYS VAL ALA HIS SEQRES 10 A 250 ALA LEU ALA GLU GLY LEU GLY VAL ILE ALA CYS ILE GLY SEQRES 11 A 250 GLU LYS LEU ASP GLU ARG GLU ALA GLY ILE THR GLU LYS SEQRES 12 A 250 VAL VAL PHE GLU GLN THR LYS VAL ILE ALA ASP ASN VAL SEQRES 13 A 250 LYS ASP TRP SER LYS VAL VAL LEU ALA TYR GLU PRO VAL SEQRES 14 A 250 TRP ALA ILE GLY THR GLY LYS THR ALA THR PRO GLN GLN SEQRES 15 A 250 ALA GLN GLU VAL HIS GLU LYS LEU ARG GLY TRP LEU LYS SEQRES 16 A 250 SER ASN VAL SER ASP ALA VAL ALA GLN SER THR ARG ILE SEQRES 17 A 250 ILE TYR GLY GLY SER VAL THR GLY ALA THR CYS LYS GLU SEQRES 18 A 250 LEU ALA SER GLN PRO ASP VAL ASP GLY PHE LEU VAL GLY SEQRES 19 A 250 GLY ALA SER LEU LYS PRO GLU PHE VAL ASP ILE ILE ASN SEQRES 20 A 250 ALA LYS GLN SEQRES 1 B 250 GLY SER ALA PRO SER ARG LYS PHE PHE VAL GLY GLY ASN SEQRES 2 B 250 TRP LYS MET ASN GLY ARG LYS GLN SER LEU GLY GLU LEU SEQRES 3 B 250 ILE GLY THR LEU ASN ALA ALA LYS VAL PRO ALA ASP THR SEQRES 4 B 250 GLU VAL VAL CYS ALA PRO PRO THR ALA TYR ILE ASP PHE SEQRES 5 B 250 ALA ARG GLN LYS LEU ASP PRO LYS ILE ALA VAL ALA ALA SEQRES 6 B 250 GLN ASN CYS TYR LYS VAL THR ASN GLY ALA PHE THR GLY SEQRES 7 B 250 GLU ILE SER PRO GLY MET ILE LYS ASP CYS GLY ALA THR SEQRES 8 B 250 TRP VAL VAL LEU GLY HIS SER GLU ARG ARG HIS VAL PHE SEQRES 9 B 250 GLY GLU SER ASP GLU LEU ILE GLY GLN LYS VAL ALA HIS SEQRES 10 B 250 ALA LEU ALA GLU GLY LEU GLY VAL ILE ALA CYS ILE GLY SEQRES 11 B 250 GLU LYS LEU ASP GLU ARG GLU ALA GLY ILE THR GLU LYS SEQRES 12 B 250 VAL VAL PHE GLU GLN THR LYS VAL ILE ALA ASP ASN VAL SEQRES 13 B 250 LYS ASP TRP SER LYS VAL VAL LEU ALA TYR GLU PRO VAL SEQRES 14 B 250 TRP ALA ILE GLY THR GLY LYS THR ALA THR PRO GLN GLN SEQRES 15 B 250 ALA GLN GLU VAL HIS GLU LYS LEU ARG GLY TRP LEU LYS SEQRES 16 B 250 SER ASN VAL SER ASP ALA VAL ALA GLN SER THR ARG ILE SEQRES 17 B 250 ILE TYR GLY GLY SER VAL THR GLY ALA THR CYS LYS GLU SEQRES 18 B 250 LEU ALA SER GLN PRO ASP VAL ASP GLY PHE LEU VAL GLY SEQRES 19 B 250 GLY ALA SER LEU LYS PRO GLU PHE VAL ASP ILE ILE ASN SEQRES 20 B 250 ALA LYS GLN FORMUL 3 HOH *460(H2 O) HELIX 1 1 ARG A 17 ALA A 30 1 14 HELIX 2 2 PRO A 44 ALA A 46 5 3 HELIX 3 3 TYR A 47 LEU A 55 1 9 HELIX 4 4 SER A 79 CYS A 86 1 8 HELIX 5 5 HIS A 95 HIS A 100 1 6 HELIX 6 6 SER A 105 GLU A 119 1 15 HELIX 7 7 LYS A 130 GLY A 137 1 8 HELIX 8 8 ILE A 138 ASN A 153 1 16 HELIX 9 9 PRO A 166 ILE A 170 5 5 HELIX 10 10 THR A 177 VAL A 196 1 20 HELIX 11 11 SER A 197 THR A 204 1 8 HELIX 12 12 THR A 216 GLN A 223 1 8 HELIX 13 13 GLY A 232 LYS A 237 5 6 HELIX 14 14 PRO A 238 ASN A 245 1 8 HELIX 15 15 ARG B 17 ASN B 29 1 13 HELIX 16 16 PRO B 44 ALA B 46 5 3 HELIX 17 17 TYR B 47 LEU B 55 1 9 HELIX 18 18 SER B 79 CYS B 86 1 8 HELIX 19 19 HIS B 95 VAL B 101 1 7 HELIX 20 20 SER B 105 GLU B 119 1 15 HELIX 21 21 LYS B 130 GLU B 135 1 6 HELIX 22 22 ILE B 138 ASP B 152 1 15 HELIX 23 23 ASP B 156 SER B 158 5 3 HELIX 24 24 PRO B 166 ILE B 170 5 5 HELIX 25 25 THR B 177 VAL B 196 1 20 HELIX 26 26 SER B 197 GLN B 202 1 6 HELIX 27 27 THR B 216 GLN B 223 1 8 HELIX 28 28 GLY B 232 LEU B 236 5 5 HELIX 29 29 LYS B 237 PRO B 238 5 2 HELIX 30 30 GLU B 239 ILE B 244 1 6 SHEET 1 A 9 PHE A 6 ASN A 11 0 SHEET 2 A 9 THR A 37 ALA A 42 1 O GLU A 38 N PHE A 6 SHEET 3 A 9 ALA A 60 ALA A 63 1 O ALA A 62 N CYS A 41 SHEET 4 A 9 TRP A 90 LEU A 93 1 O VAL A 92 N ALA A 63 SHEET 5 A 9 VAL A 123 ILE A 127 1 O CYS A 126 N LEU A 93 SHEET 6 A 9 VAL A 160 TYR A 164 1 O ALA A 163 N ILE A 127 SHEET 7 A 9 ILE A 206 TYR A 208 1 O ILE A 207 N LEU A 162 SHEET 8 A 9 GLY A 228 VAL A 231 1 O GLY A 228 N TYR A 208 SHEET 9 A 9 PHE A 6 ASN A 11 1 N ASN A 11 O VAL A 231 SHEET 1 B 9 PHE B 6 ASN B 11 0 SHEET 2 B 9 THR B 37 ALA B 42 1 O VAL B 40 N GLY B 10 SHEET 3 B 9 ALA B 60 ALA B 63 1 O ALA B 60 N CYS B 41 SHEET 4 B 9 TRP B 90 LEU B 93 1 O TRP B 90 N ALA B 63 SHEET 5 B 9 GLY B 122 ILE B 127 1 O CYS B 126 N LEU B 93 SHEET 6 B 9 VAL B 160 TYR B 164 1 O ALA B 163 N ILE B 127 SHEET 7 B 9 ARG B 205 TYR B 208 1 O ARG B 205 N LEU B 162 SHEET 8 B 9 GLY B 228 VAL B 231 1 O GLY B 228 N TYR B 208 SHEET 9 B 9 PHE B 6 ASN B 11 1 N ASN B 11 O VAL B 231 CRYST1 46.564 70.883 141.412 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021476 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014108 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007072 0.00000